Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Russell Raymond, DO, is an Interventional Cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine. He is certified by the American Board of Internal Medicine in internal medicine, cardiology and interventional cardiology. Dr. Raymond specializes in cardiac catheterization and high-risk coronary interventions including angioplasty, stent and atherectomy (directional and rotational). He also has a special interest in the use of hemodynamic support devices including intraaortic balloon pump, Impeller, and ECMO; and investigational devices and intracoronary ultrasound
Following his undergraduate degree from Asbury College in Kentucky, Dr. Raymond graduated as a Doctor of Osteopathic Medicine from the Chicago College of Osteopathic Medicine. He interned at Doctor’s Hospital in Columbus, Ohio, and completed his internal medicine residency at Cleveland Clinic. He accepted a fellowship from the Cleveland Clinic for advanced training in cardiology followed by a special fellowship in interventional cardiology. He has been with Cleveland Clinic as an Interventional Cardiologist since 1988.
Dr. Raymond has long been involved in many clinical research studies related to cardiac issues. Currently, he is Principal Cleveland Clinic Investigator in the ABSORB Trial on the treatment of coronary disease using a bioresorbable platform that "dissolves" after two years leaving nothing behind unlike present day metal stents. He is a CO-investigator in the EXCEL trial, a randomized trial comparing coronary bypass surgery and percutaneous intervention for the treatment of severe triple vessel disease including left main trunk lesions. Dr. Raymond is also a Co-Investigator on many other current clinical studies related to the evaluation and treatment of heart disease.
Dr. Raymond is the co-author of chapters in medical textbooks on pregnancy and heart disease and on coronary artery perforation. He has published numerous articles and abstracts in leading peer-reviewed publications on his research work and his clinical experience, including Circulation, Catheterization and Cardiovascular Diagnosis, Journal of the American College of Cardiology and European Heart Journal, to name a few.
Dr. Raymond is a Fellow of the American College of Cardiology (FACC) and a Fellow of the Society of Cardiac Angiography and Interventions (FSCAI). He is a member of the American Heart Association, the American Osteopathic Association, the Ohio Osteopathic Association and the American College of Osteopathic Internists.
Every February, Dr. Raymond leads a medical mission team to Honduras. He also enjoys being a member of the Fellowship of Christian Athletes, the Christian Medical and Dental Association and, in his leisure time, enjoys playing golf.
Coronary artery disease, stent restenosis, total coronary occlusions, angioplasty, rotational atherectomy, stent-coronary, coronary artery atherectomy, coronary intervention, drug eluting stenting, and the use of hemodynamic support devices including intraaortic balloon pump, Impeller, and ECMO. Coronary artery disease, stent restenosis, total coronary occlusions, angioplasty, rotational atherectomy, stent-coronary, coronary artery atherectomy, coronary intervention, drug eluting stenting
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/17/2013, Dr. Raymond has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.